Skip to content

Clinical trials

Phase 3 Neurotoxicity Syndromes trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neurotoxicity Syndromes Phase: Phase 3 Clear all

33 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20023
20031
20041
20051
20063
20073
20084
20095
20101
20112
20121
20133
20151
20171
20221
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed21
Unknown status5
Terminated2
Active, not recruiting2
Suspended1
Enrolling by invitation1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alliance for Clinical Trials in Oncology11
Gynecologic Oncology Group3
Tianjin Medical University Cancer Institute and Hospital3
Sanofi2
Sun Yat-sen University2
BioNumerik Pharmaceuticals, Inc.1
Eastern Cooperative Oncology Group1
Ellis Medicine1
Gary Morrow1
M.D. Anderson Cancer Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neurotoxicity Syndromes33
Pain8
Colorectal Neoplasms7
Neoplasm Metastasis5
Breast Neoplasms4
Peripheral Nervous System Diseases4
Brain Neoplasms3
Colonic Neoplasms3
Fatigue3
Leukemia3

Trials

Showing 76 to 33 of 33. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.